19 October 2018 - - US-based biotechnology company Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) has appointed Francois Lebel, M.D., F.R.C.P.C. as chief medical officer, the company said.

Lebel will be responsible for leading the Spectru...
19 October 2018 - - A pivotal Phase 3 KEYNOTE-426 trial investigating US-based biopharmaceutical company Merck's (NYSE: MRK) Keytruda (pembrolizumab), Merck's anti-PD-1 therapy, in combination with Inlyta (axitinib), Pfizer's (NYS...
19 October 2018 - - US-based molecular diagnostics company Co-Diagnostics, Inc.'s (NASDAQ: CODX) Logix Smart Zika Test technical file has obtained CE mark approval, the principle regulatory clearance allowing the test to be sold as an in vi...
19 October 2018 - Chinese biopharmaceutical company Innovent Biologics Inc revealed on Thursday that it has dosed the first patient with advanced solid tumors under a phase I clinical trial of anti-CTLA-4 (Cytotoxic T Lymphocyte-associated Antigen-4)...
19 October 2018 - Biotechnology company Morphic Therapeutic said on Thursday that it plans to advance a number of its oral integrin therapeutics for fibrosis-related indications under a research and development collaboration with AbbVie (NYSE:ABBV) s...